Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:00 PM
Ignite Modification Date:
2025-12-26 @ 4:00 PM
NCT ID:
NCT00671606
Eligibility Criteria:
Inclusion Criteria:
1. Patients with biopsy confirmed endometrial cancer who have been dispositioned to undergo total hysterectomy, bilateral salpingooophorectomy and lymph node staging.
2. Surgical procedures may be performed by either laparotomy or laparoscopy.
3. If computed tomography, magnetic resonance imaging, lymphangiography, or ultrasound has been performed for preoperative assessment, there must be no evidence of metastases. Imaging is not mandatory.
4. Patients who have signed an approved informed consent and authorization permitting release of personal health information.
Exclusion Criteria:
1. Patients with a preoperative diagnosis of grade I endometrioid adenocarcinoma of the uterus.
2. Patients with uterine papillary serous carcinoma.
3. Patients who have undergone endometrial ablation or a myomectomy within 1 year of the surgery for endometrial cancer.
4. Patients with known allergies to triphenylmethane compounds or technetium-99 radiocolloid.
5. Patients with a history of retroperitoneal surgery.
6. Patients with a history of pelvic radiation.
7. Patients with no lesion visible on hysteroscopy.
8. Patients with previous exposure to the tracer (to prevent risk of allergic reaction).
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT00671606
Study Brief:
Protocol Section:
NCT00671606